Kenneth J. Hillan - Dec 7, 2023 Form 4 Insider Report for Zymeworks Inc. (ZYME)

Role
Director
Signature
/s/ Daniel Dex, Attorney-in-Fact
Stock symbol
ZYME
Transactions as of
Dec 7, 2023
Transactions value $
$0
Form type
4
Date filed
12/8/2023, 05:17 PM
Previous filing
Jun 7, 2023
Next filing
Jun 6, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZYME Stock Option (Right to Buy) Award $0 +37K $0.00 37K Dec 7, 2023 Common Stock 37K $9.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options vest on date of next annual general meeting following grant date of December 7, 2023.